Regent Pacific Group 
Welcome,         Profile    Billing    Logout  
 5 Products   0 Diseases  5 Products   8 Trials   64 News 
8 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Urolieve (lidocaine alkalized intravesicular) / Regent Pacific Group
ChiCTR2400079597: Efficacy of lidocaine intravesical administration in treating moderate to severe catheter-related bladder discomfort after surgery

Not yet recruiting
4
76
 
lidocaine intravesical administration; Normal saline intravesical administration
no sponsor; The Second Affiliated Hospital of Zhengzhou University, self expense
CRBD
 
 
NCT06514430: Prophylactic Analgesia for Bladder Botox Injections

Not yet recruiting
4
120
US
Phenazopyridine, Pyridium, 1% lidocaine with sodium bicarbonate, Intravesical lidocaine
Montefiore Medical Center
Urinary Incontinence, Urinary Incontinence, Urge, Overactive Bladder
12/25
12/25
2021-000559-38: The effect of bladder installed local anesthetic solution prior to Botox injections in the bladder

Not yet recruiting
3
50
Europe
Injection, Solvent for parenteral use, Lidokain SAD, Natriumbikarbonat SAD, Natriumklorid "Fresenius Kabi" 9 mg/ml
Herlev and Gentofte University Hospital, Department of Obstetrics and Gynecology, Herlev and Gentofte Hospital’s Research Fund
The effect of intravesical Lidocaine solution versus placebo on pain perception during intravesical injection of Onabotulinum toxin A., Pain experience during injection of Onabotulinum toxin A in the bladder, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
 
 
NCT05415865: The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder

Recruiting
3
50
Europe
Alkalinized Lidocaine, Placebo Sodium Chloride 0.9% Inj
Herlev and Gentofte Hospital, Region Hovedstadens Apotek
Urge Incontinence, Overactive Bladder, Anesthesia, Local, Pain, Procedural, Urinary Tract Infections, Hematuria
04/24
05/24
ChiCTR-INR-15007438: The effects of intravesical alkalinized lidocaine in combination with atropine on catheter-related bladder discomfort

Recruiting
N/A
150
 
infusion of diluated atropine (27ml) ;2% lidocaine 20ml + Atropine 1mg/2ml + 0.9% NS 5ml ;2% lidocaine 20ml + Atropine 1mg/2ml + 5% Sodium bicarbonate 5ml
The Fourth Affiliated Hospital of Harbin Medical University; The Fourth Affiliated Hospital of Harbin Medical University, science research fund
Catheter related bladder discomfort
 
 
PSD506 / Regent Pacific Group
2006-001334-40: A double-blind, placebo controlled study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients symptoms of overactive bladder (OAB)

 
2
30
Europe
PSD506, PSD506,
PLETHORA SOLUTIONS LIMITED
overactive bladder (OAB)
 
 
2006-002055-32: A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients with benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS)

 
2
60
Europe
PSD506, PSD506,
Plethora Solutions Limited
benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS)
 
11/07
2006-002663-11: An open-label, escalating dose, proof of concept study to determine the effects of single oral doses of PSD506 on unstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12

Ongoing
2
18
Europe
PSD506, PSD506,
Plethora Solutions Limited
Unstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12.
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Urolieve (lidocaine alkalized intravesicular) / Regent Pacific Group
ChiCTR2400079597: Efficacy of lidocaine intravesical administration in treating moderate to severe catheter-related bladder discomfort after surgery

Not yet recruiting
4
76
 
lidocaine intravesical administration; Normal saline intravesical administration
no sponsor; The Second Affiliated Hospital of Zhengzhou University, self expense
CRBD
 
 
NCT06514430: Prophylactic Analgesia for Bladder Botox Injections

Not yet recruiting
4
120
US
Phenazopyridine, Pyridium, 1% lidocaine with sodium bicarbonate, Intravesical lidocaine
Montefiore Medical Center
Urinary Incontinence, Urinary Incontinence, Urge, Overactive Bladder
12/25
12/25
2021-000559-38: The effect of bladder installed local anesthetic solution prior to Botox injections in the bladder

Not yet recruiting
3
50
Europe
Injection, Solvent for parenteral use, Lidokain SAD, Natriumbikarbonat SAD, Natriumklorid "Fresenius Kabi" 9 mg/ml
Herlev and Gentofte University Hospital, Department of Obstetrics and Gynecology, Herlev and Gentofte Hospital’s Research Fund
The effect of intravesical Lidocaine solution versus placebo on pain perception during intravesical injection of Onabotulinum toxin A., Pain experience during injection of Onabotulinum toxin A in the bladder, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
 
 
NCT05415865: The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder

Recruiting
3
50
Europe
Alkalinized Lidocaine, Placebo Sodium Chloride 0.9% Inj
Herlev and Gentofte Hospital, Region Hovedstadens Apotek
Urge Incontinence, Overactive Bladder, Anesthesia, Local, Pain, Procedural, Urinary Tract Infections, Hematuria
04/24
05/24
ChiCTR-INR-15007438: The effects of intravesical alkalinized lidocaine in combination with atropine on catheter-related bladder discomfort

Recruiting
N/A
150
 
infusion of diluated atropine (27ml) ;2% lidocaine 20ml + Atropine 1mg/2ml + 0.9% NS 5ml ;2% lidocaine 20ml + Atropine 1mg/2ml + 5% Sodium bicarbonate 5ml
The Fourth Affiliated Hospital of Harbin Medical University; The Fourth Affiliated Hospital of Harbin Medical University, science research fund
Catheter related bladder discomfort
 
 
PSD506 / Regent Pacific Group
2006-001334-40: A double-blind, placebo controlled study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients symptoms of overactive bladder (OAB)

 
2
30
Europe
PSD506, PSD506,
PLETHORA SOLUTIONS LIMITED
overactive bladder (OAB)
 
 
2006-002055-32: A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients with benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS)

 
2
60
Europe
PSD506, PSD506,
Plethora Solutions Limited
benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS)
 
11/07
2006-002663-11: An open-label, escalating dose, proof of concept study to determine the effects of single oral doses of PSD506 on unstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12

Ongoing
2
18
Europe
PSD506, PSD506,
Plethora Solutions Limited
Unstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12.
 
 

Download Options